Annual Revenue
$28.83 M
-$9.19 M-24.17%
December 31, 2024
Summary
- As of March 14, 2025, ABCL annual revenue is $28.83 million, with the most recent change of -$9.19 million (-24.17%) on December 31, 2024.
- During the last 3 years, ABCL annual revenue has fallen by -$346.37 million (-92.32%).
- ABCL annual revenue is now -94.06% below its all-time high of $485.42 million, reached on December 31, 2022.
Performance
ABCL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$5.05 M
-$1.46 M-22.39%
December 31, 2024
Summary
- As of March 14, 2025, ABCL quarterly revenue is $5.05 million, with the most recent change of -$1.46 million (-22.39%) on December 31, 2024.
- Over the past year, ABCL quarterly revenue has dropped by -$1.46 million (-22.39%).
- ABCL quarterly revenue is now -98.40% below its all-time high of $316.58 million, reached on March 31, 2022.
Performance
ABCL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$28.83 M
-$4.13 M-12.53%
December 31, 2024
Summary
- As of March 14, 2025, ABCL TTM revenue is $28.83 million, with the most recent change of -$4.13 million (-12.53%) on December 31, 2024.
- Over the past year, ABCL TTM revenue has dropped by -$4.13 million (-12.53%).
- ABCL TTM revenue is now -95.22% below its all-time high of $603.21 million, reached on September 30, 2022.
Performance
ABCL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ABCL Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.2% | -22.4% | -12.5% |
| 3 y3 years | -92.3% | -22.4% | -12.5% |
| 5 y5 years | +148.3% | -22.4% | -12.5% |
ABCL Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.1% | at low | -98.4% | at low | -95.2% | at low |
| 5 y | 5-year | -94.1% | +148.3% | -98.4% | +57.7% | -95.2% | +800.3% |
| alltime | all time | -94.1% | +226.5% | -98.4% | +57.7% | -95.2% | +800.3% |
AbCellera Biologics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $28.83 M(-24.2%) | $5.05 M(-22.4%) | $28.83 M(-12.5%) |
| Sep 2024 | - | $6.51 M(-11.1%) | $32.96 M(-0.3%) |
| Jun 2024 | - | $7.32 M(-26.4%) | $33.05 M(-7.6%) |
| Mar 2024 | - | $9.95 M(+8.4%) | $35.79 M(-5.9%) |
| Dec 2023 | $38.02 M(-92.2%) | $9.18 M(+39.1%) | $38.03 M(-24.5%) |
| Sep 2023 | - | $6.60 M(-34.4%) | $50.39 M(-65.3%) |
| Jun 2023 | - | $10.06 M(-17.5%) | $145.18 M(-19.8%) |
| Mar 2023 | - | $12.19 M(-43.4%) | $181.04 M(-62.7%) |
| Dec 2022 | $485.42 M | $21.55 M(-78.7%) | $485.43 M(-19.5%) |
| Sep 2022 | - | $101.38 M(+120.8%) | $603.21 M(+18.9%) |
| Jun 2022 | - | $45.92 M(-85.5%) | $507.34 M(+3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $316.58 M(+127.2%) | $489.06 M(+30.3%) |
| Dec 2021 | $375.20 M(+60.9%) | $139.33 M(+2429.6%) | $375.22 M(-15.5%) |
| Sep 2021 | - | $5.51 M(-80.1%) | $443.80 M(-0.9%) |
| Jun 2021 | - | $27.64 M(-86.4%) | $447.65 M(+3.8%) |
| Mar 2021 | - | $202.74 M(-2.5%) | $431.24 M(+85.0%) |
| Dec 2020 | $233.16 M(+1907.9%) | $207.91 M(+2120.8%) | $233.16 M(+719.5%) |
| Sep 2020 | - | $9.36 M(-16.6%) | $28.45 M(+49.0%) |
| Jun 2020 | - | $11.23 M(+141.1%) | $19.09 M(+142.9%) |
| Mar 2020 | - | $4.66 M(+45.4%) | $7.86 M(+145.4%) |
| Dec 2019 | $11.61 M(+31.5%) | $3.20 M | $3.20 M |
| Dec 2018 | $8.83 M | - | - |
FAQ
- What is AbCellera Biologics annual revenue?
- What is the all time high annual revenue for AbCellera Biologics?
- What is AbCellera Biologics annual revenue year-on-year change?
- What is AbCellera Biologics quarterly revenue?
- What is the all time high quarterly revenue for AbCellera Biologics?
- What is AbCellera Biologics quarterly revenue year-on-year change?
- What is AbCellera Biologics TTM revenue?
- What is the all time high TTM revenue for AbCellera Biologics?
- What is AbCellera Biologics TTM revenue year-on-year change?
What is AbCellera Biologics annual revenue?
The current annual revenue of ABCL is $28.83 M
What is the all time high annual revenue for AbCellera Biologics?
AbCellera Biologics all-time high annual revenue is $485.42 M
What is AbCellera Biologics annual revenue year-on-year change?
Over the past year, ABCL annual revenue has changed by -$9.19 M (-24.17%)
What is AbCellera Biologics quarterly revenue?
The current quarterly revenue of ABCL is $5.05 M
What is the all time high quarterly revenue for AbCellera Biologics?
AbCellera Biologics all-time high quarterly revenue is $316.58 M
What is AbCellera Biologics quarterly revenue year-on-year change?
Over the past year, ABCL quarterly revenue has changed by -$1.46 M (-22.39%)
What is AbCellera Biologics TTM revenue?
The current TTM revenue of ABCL is $28.83 M
What is the all time high TTM revenue for AbCellera Biologics?
AbCellera Biologics all-time high TTM revenue is $603.21 M
What is AbCellera Biologics TTM revenue year-on-year change?
Over the past year, ABCL TTM revenue has changed by -$4.13 M (-12.53%)